Ema, green light for the Pfizer-BioNTech vaccine | It can be administered to those over 16 years of age.

Von der Leyen: “Now we will act quickly on the vaccine” – “This is a watershed moment in our efforts to provide safe and effective vaccines to Europeans. The EMA has just issued a positive scientific opinion on the BioNTech / Pfizer vaccine. We will now act quickly. I await a decision from the European Commission by tonight.” . The president of the European Commission, Ursula von der Leyen, writes on Twitter.

Ema: “We guarantee the safety and efficacy of vaccines to citizens” – “Today’s positive news represents an important step forward in our fight against this pandemic.” This was added by the director of the EMA, Emer Cooke. “We have reached this milestone thanks to the dedication of scientists, doctors and trial volunteers, as well as many experts from all EU member states – he added – We can guarantee to EU citizens the safety and efficacy of this vaccine” . that meets the necessary quality standards. “” However, our work does not stop there. We will continue to collect and analyze data on the safety and efficacy of this vaccine to protect people taking the vaccine in the EU, “he added.

In a few hours, the EU will authorize trade: The European Commission should give the authorization for the Pfizer-BioNTech vaccine to be marketed in the afternoon, after Ema’s approval. “I expect a decision from the European Commission by tonight,” wrote President Ursula von der Leyen on Twitter.

Ema: even with the vaccine, keep precautions and distances – “Our recommendations are to continue to wash hands frequently, wear masks and maintain physical distance because at the moment we cannot be sure that vaccination will prevent contagion and an experiment is being carried out on this,” Harald said. Enzmann, Chairman of the Committee for Human Medicines (CHMP) of the European Medicines Agency (EMA).